Topical Imiquimod for Bowen's Disease of the Head and Neck
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
- Double blinded, randomized, placebo controlled trial of imiquimod for the treatment of
histologically proven Bowens disease of the head and neck.
- Null hypothesis: No difference in histologic clearance rates of patients with head or
neck Bowens treated with imiquimod versus placebo.
- Outcome: Histologic clearance of Bowens disease at T=14 weeks.